GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPS Pharmaa Ltd (BOM:531686) » Definitions » Financial Strength

MPS Pharmaa (BOM:531686) Financial Strength : 6 (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is MPS Pharmaa Financial Strength?

MPS Pharmaa has the Financial Strength Rank of 6.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

MPS Pharmaa did not have earnings to cover the interest expense. As of today, MPS Pharmaa's Altman Z-Score is 0.00.


Competitive Comparison of MPS Pharmaa's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, MPS Pharmaa's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPS Pharmaa's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPS Pharmaa's Financial Strength distribution charts can be found below:

* The bar in red indicates where MPS Pharmaa's Financial Strength falls into.


;
;

MPS Pharmaa Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

MPS Pharmaa's Interest Expense for the months ended in Dec. 2024 was ₹-0.00 Mil. Its Operating Income for the months ended in Dec. 2024 was ₹-2.22 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0.00 Mil.

MPS Pharmaa's Interest Coverage for the quarter that ended in Dec. 2024 is

MPS Pharmaa did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

MPS Pharmaa's Debt to Revenue Ratio for the quarter that ended in Dec. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 0
=N/A

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

MPS Pharmaa has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MPS Pharmaa  (BOM:531686) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

MPS Pharmaa has the Financial Strength Rank of 6.


MPS Pharmaa Financial Strength Related Terms

Thank you for viewing the detailed overview of MPS Pharmaa's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


MPS Pharmaa Business Description

Traded in Other Exchanges
N/A
Address
Barakhamba Road, Connaught Place, 703, Arunachal building 19, New Delhi, IND, 110001
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and export of Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory and antibacterials & antibiotics.

MPS Pharmaa Headlines

No Headlines